Skip to main content
The Journal of Clinical and Aesthetic Dermatology logoLink to The Journal of Clinical and Aesthetic Dermatology
. 2021 Jan 1;14(1):55–58.

A Case of Subacute Necrotizing Fasciitis due to Serratia marcescens

Michael Roberts 1,2,3,✉, David Crasto 1,2,3, David Roy 1,2,3
PMCID: PMC7869816  PMID: 33584969

Abstract

Necrotizing fasciitis (NF) is a progressive inflammatory infection of the fascia that is often aggressive and advances insidiously. NF can be preceded by traumatic injury or surgical intervention or may occur spontaneously. Here, we describe a patient who presented with monomicrobial subacute necrotizing fasciitis due to Serratia marcescens. Dermatology was consulted at the local hospital for suspected cellulitis with no resolution using appropriate antibiotics. Our patient failed to show improvement with antibiotic treatment and experienced an above-the-knee amputation. We have also included a review of the current literature on subacute necrotizing fasciitis and S. marcescens. A case review of 25 patients resulted in rates of 52.1% for overall mortality, 72% for mortality among patients treated with only antibiotics, and 40% for mortality among patients treated with surgical debridement. There needs to be a high suspicion for necrotizing fasciitis even in patients presenting with cellulitis without systemic symptoms. If S. marcescens is isolated, more aggressive treatment may be warranted. More cases of subacute necrotizing fasciitis and S. marcescens need to be reported in the literature to better understand early diagnosis and best management practices.

Keywords: Subacute, necrotizing, fasciitis, Serratia marcescens


Necrotizing fasciitis (NF) is a progressive inflammatory infection of the fascia that is often aggressive and advances insidiously. NF can be preceded by traumatic injury or surgical intervention may occur spontaneously.1 The infection initially causes necrosis of the fascia and subcutaneous tissue, while sparing the muscle and dermal tissue. The bacteria express toxins and progress along the fascial plane, causing devascularization of muscle and cutaneous tissue.2 Devascularization occurs as a result of thrombosis of the cutaneous perforating vessels, causing rapid tissue necrosis.3 The current recommended guidelines for NF treatment are broad empiric antibiotics, clindamycin for group A Streptococcus infection, and prompt surgical consultation.4

NF most commonly affects the extremities but can involve any part of the body. The staging system proposed by Wang et al5 describes the common presentation of NF. Stage 1 (early) is frequently associated with erythema, swelling, and pain, with palpation beyond the presenting site. Stage 2 (intermediate) is evidenced by the formation of bullae or serous filled blisters. Stage 3 (late) manifests as skin anesthesia, crepitus, hemorrhagic bullae, and dusky discoloration.1,6,7

Necrotizing soft tissue infections are classified on the basis of anatomic location, depth, and microbial cause.8 The depth of infection can reach adipocytes, fascia, and muscle. There are three types of microbial classifications. Type I contains mixed microbes, including aerobic and anaerobic bacteria. Type II is monomicrobial and most commonly involves group A Streptococcus or Staphylococcus aureus. Type III involves Vibrio vulnificus, although this classification is not universally agreed upon.9 Multimicrobial infections are more common than monomicrobial infections. Monomicrobial infections tend to affect younger, healthier individuals with a history of minor trauma.10

Serratia marcescens is a rare cause of NF. S. marcescens is a motile, Gram-negative, facultative anaerobe and a member of the Enterobacteriaceae family, which is maintained in the normal colonic flora.11 In recent years, reports of S. marcescens respiratory-tract infections, urinary-tract infections, septicemia, meningitis, and wound infections have increased.11 The factors predisposing individuals to infections include but are not limited to trauma, alcoholism, peripheral vascular disease, immunosuppression, diabetes mellitus, antibiotic use, steroid use, intravenous lines, lacerations, and abscesses.12 One study reported a 52-percent mortality rate for S. marcescens NF.12

Limited reports have described a rare, subacute presentation of NF that lacks the aggressive clinical features typically seen with NF and instead demonstrates an indolent course followed by sudden, rapid deterioration.13–17 Vascular insufficiency, cellulitis, or other soft-tissue infections can easily mimic this condition due to the lack of apparent severity at onset. The definitive treatment includes surgical intervention via fasciotomy and debridement to prevent limb loss and potentially death. Establishing accepted criteria is critical to support early disease recognition.14

Here, we present a case of subacute NF that was caused by S. marcescens and resulted in partial amputation. We also discuss the current literature and diagnostic parameters.

CASE REPORT

A 73-year-old African-American female patient with a medical history of hypertension and hypercholesterolemia presented to the emergency department with a two-week history of weakness and painful swelling in her bilateral lower extremities. Seven days prior, she had sought care at a local outpatient clinic, where she received furosemide for a suspected chronic heart failure exacerbation. At that time, examination of her legs revealed erythema, tenderness to palpation, and edema, which was worse on the right leg. There was no mention of induration or bullae.

The patient later presented to the emergency department. At that time, her right lower leg and foot displayed erythema, induration, and small, tense bullae of the right lower extremity. After admission, laboratory analysis indicated a white blood cell count of 7.4×109/L, a blood glucose level of 65mg/dL, and a lactic acid level of 3.6mmol/L. She was treated empirically for cellulitis with suspected sepsis. Blood and wound cultures revealed S. marcescens. Her condition continued to deteriorate despite the addition of aztreonam and ceftriaxone. Over the course of six days, tense, painful hemorrhagic bullae with significant edema of the dorsum of the foot developed, extending into the distal phalanges (Figures 1 and 2). Induration of the tissue extended beyond clinically apparent erythema. At no point during her course did she develop an elevated white blood cell count, pyrexia, or elevated glucose levels.

FIGURE 1.

FIGURE 1.

Necrosis of the right foot with surrounding erythema and significant edema

FIGURE 2.

FIGURE 2.

Necrotic ulceration of the right knee and lower leg with edema

The dermatology department was consulted and a diagnosis of NF was made after examination. The surgery department was immediately consulted and the patient underwent an above-the-knee amputation of the right lower extremity. She was later transferred to a transitional care facility and was ultimately able to return home.

DISCUSSION

NF is often misdiagnosed at the time of admission to the hospital, and consequently, can lead to high morbidity and mortality rates.15 The mortality rates reported in studies are approximately 24 to 34 percent and are lower with early diagnosis and treatment.18,19 This patient’s subacute presentation was a slowly worsening leg pain of two weeks’ duration, with no additional symptoms aside from weakness. At presentation to the emergency department, she was tachycardic, without meeting Systemic Inflammatory Response Syndrome criteria. Her laboratory results also did not meet the criteria for sepsis or suggest NF and she was treated with the proper antibiotics. She had a delayed diagnosis and an acute deterioration, which resulted in an above-the-knee amputation.

The true incidence of subacute NF is likely misrepresented in the literature.14 Because of the subtle features and lack of symptomatic severity, the diagnosis of subacute NF can be exceedingly difficult.14,15 Furthermore, the point at which the clinical decline will occur is difficult to predict accurately. According to a review by Wong and Tan16 in 2006, NF features can present as early as six days or greater than one month after the onset of symptoms.16 Failure to consider NF as a diagnosis during this indolent period can be detrimental to patients because early surgical debridement is key to reducing morbidity and mortality rates.14–17 Wong and Tan16 proposed a four-stage grading system, which our patient also followed (Table 1).

TABLE 1.

Stages of subacute necrotizing fasciitis, according to Wong et al16

Stage 1 Initial indolent course without signs of systemic toxicity
Stage 2 Gradual tissue necrosis with possible overlying cutaneous findings
Stage 3 Progression despite proper use of antimicrobials
Stage 4 Sudden deterioration to NF with septic features

Our patient presented with type II monomicrobial S. marcescens NF of the right lower leg. S. marcescens has increasingly been identified as a causative pathogen in NF. A case review by Lakhani et al12 described 15 cases from 1987 to 2015, and 10 new cases have since been added to the literature (Table 2), two of which were multimicrobial.12,19,36 There is currently insufficient statistical power to understand the effects of S. marcescens on NF. The average age of infection is 49.2 (± 21.9 years) and a 52.1 percent rate of mortality has been reported, not counting two patients who were lost to follow-up after leaving the hospital against medical advice. Patients treated with only antibiotics show a 72-percent mortality rate, while those treated with surgical debridement present a 40-percent mortality rate.

TABLE 2.

S. Marcescens NF cases (1966–Present)*

STUDY YEAR AGE (YEARS) SEX RISK FACTORS PRECIPITATING FACTOR INFECTION SITE TYPE S. MARCESCENS CULTURE TREATMENT OUTCOME
Rimailho et al.20 1987 74 M Immunocompromised Diclofenac use Leg Ca Blister and blood None Died
Bornstein et al.21 1992 37 F Renal failure on hemodialysis Pain during dialysis Axilla and chest wall HA Wound, bullae, blood Antibiotics and SD Survived
Zipper et al.22 1996 55 F DM Left below-knee amputation Leg CA Wound Antibiotics Survived
Huang et al.23 1999 73 M Nephrotic syndrome Steroid therapy Lower leg HA Necrotic tissue, blood Antibiotics and SD Survived
Huang et al.23 1999 40 M Uremia, peritoneal dialysis, SLE Pneumonia with positive cultures for S. marcescens, steroid and nabumetone Left calf and thigh CA Necrotic tissue, blood Antibiotics and SD Survived
Liangpunsakul et al.24 2001 66 F Healthy None Leg CA Blood Antibiotics Died
Newton et al.25 2002 2 F Healthy Pharyngitis Cervical spine CA Wound, blood Antibiotics and SD Died
Bachmeyer et al.26 2004 49 M Small-cell lung cancer, DM Chemotherapy and cellulitis Right leg HA Tissue, bullae, blood Antibiotics Survived
Curtis et al.27 2005 51 M ESRD, T2DM, CHF Scraped knee on rock in river Left leg CA Wound, blood Antibiotics and SD Died
Statham et al.28 2009 6 M Immunocompetent Suspected pharyngitis Oro-pharynx CA Wound, blood Antibiotics and SD Survived
Motsitsi et al.29 2011 37 M Healthy Human bite Forearm CA Wound SD Died
Vano-Galvan et al.30 2012 57 F ML, immunocompromised Minor trauma Right thigh HA Blister, blood Antibiotics Died
Prelog et al.31 2012 15 F Acute lymphocytic leukemia Venous access-port implantation Left axilla, venous HA access port site HA Wound Antibiotics and SD Survived
Wen32 2012 40 F Nephrotic syndrome, cyclosporine use Chemotherapy 10 days prior Left leg CA Wound, blood Antibiotics Died
Rehman et al.33 2012 54 F SLE, ESRD Central venous catheter, arteriovenous fistula ligation, steroid therapy Chest wall HA Wound, blood Antibiotics and SD Died
Cope et al.31 2013 97 F Heart failure, CKD Heart failure exacerbation Right leg HA Wound (post-mortem) Antibiotics Died
Lakhani et al.12 2015 51 F DM, PVD Bifemoral bypass and left distal femoral aneurysm repair Lower abdomen HA Wound, blood Antibiotics and SD Survived
Majumdar et al.35 2016 54 F DM, ESRD Leg wound due to calciphylaxis, recent skin biopsy Left leg HA Wound Antibiotics and SD Died
Haguiya et al.36 2016 64 M Cirrhosis, hepatocellular carcinoma Leg wound due to burn Left leg CA Blood, Soft tissue Antibiotics Died
Lin et al.37 2016 56 M DM, betel nut chewing Tooth extraction Oropharynx CA Blood Antibiotics and SD Died
Tuler et al.19 2016 12 F Healthy Left leg trauma Left leg CA Wound Antibiotics and SD Survived
Heigh et al.38 2016 60 M DM, CAD, cirrhosis Laryngectomy Left foot and leg HA Blood, soft tissue Antibiotics, SD, AKA Survived
Marin et al.39 2017 55 F DM, CAD None Left foot and leg CA Wound, blood Antibiotics and SD LAMA
Marin et al.39 2017 50 M DM Right foot traumas Right foot CA Soft tissue Antibiotics and SD LAMA
Current 2018 73 F Healthy None Right leg CA Wound, blood Antibiotics, SD, AKA Survived

AKA, above-the-knee amputation; CA, community-acquired infection; CAD, coronary artery disease; CHF, chronic heart failure; CKD, chronic kidney disease; DM, diabetes mellitus; ESRD, end-stage renal disease; HA, health-care-associated infection; LAMA, left against medical advice; SD, surgical debridement; PVD, peripheral vascular disease; SLE, systemic lupus erythematosus; T2DM, type II diabetes mellitus

*Adapted from Lakhani et al.12

Our case has two interesting features— subacute presentation of NF and S. marcescens as a pathogen—that must be reported more often. When S. marcescens is diagnosed, there appears to be a greater mortality rate than that in other cases of NF. S. marcescens is associated with a 52.1-percent mortality rate as compared with that of 34-percent for general NF cases.18 Factors leading to increased mortality may include an immunocompromised state, delayed treatment, or subacute presentation. This patient presented without systemic or laboratory signs, thus delaying biopsy and debridement. More of these cases must be added to the literature to expand our knowledge of how to diagnose subacute NF to decrease morbidity and mortality rates.

REFERENCES

  1. Hasham S, Matteucci P, Stanley PR, Hart NB. Necrotising fasciitis. BMJ. 2005;330(7495):830–833. doi: 10.1136/bmj.330.7495.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goldstein EJC, Anaya DA, Dellinger EP. Necrotizing Soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–710. doi: 10.1086/511638. [DOI] [PubMed] [Google Scholar]
  3. Kiat HJ, En Natalie YH, Fatimah L. Necrotizing fasciitis: how reliable are the cutaneous signs?. J Emerg Trauma Shock. 2017;10(4):205–210. doi: 10.4103/JETS.JETS_42_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Stevens DL, Bisno AL, Chambers HF et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147–159. doi: 10.1093/cid/ciu296. [DOI] [PubMed] [Google Scholar]
  5. Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol. 2007;46(10):1036–1041. doi: 10.1111/j.1365-4632.2007.03201.x. [DOI] [PubMed] [Google Scholar]
  6. Stoneback J, Hak D. Diagnosis and management of necrotizing fasciitis. Orthopedics. 2011;34(3):196. doi: 10.3928/01477447-20110124-20. [DOI] [PubMed] [Google Scholar]
  7. Arif N, Yousfi S, Vinnard C. Deaths from necrotizing fasciitis in the United States, 2003–2013. Epidemiol Infect. 2016;144(6):1338–1344. doi: 10.1017/S0950268815002745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–288. doi: 10.1016/j.jamcollsurg.2008.10.032. [DOI] [PubMed] [Google Scholar]
  9. Ahmad H, Haider J, Siddiqui SS et al. Subacute peristomal necrotizing fasciitis detected during adjuvant chemotherapy for adenocarcinoma rectum: case report on a unique presentation and description of a simple surgical strategy for treatment. Cureus. 2018;10(1):e2075. doi: 10.7759/cureus.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Puvanendran R, Huey JC, Pasupathy S. Necrotizing fasciitis. Can Fam Physician. 2009;55(10):981–987. [PMC free article] [PubMed] [Google Scholar]
  11. Hejazi A, Falkiner FR. Serratia marcescens. J Med Microbiol. 1997;46(11):903–912. doi: 10.1099/00222615-46-11-903. [DOI] [PubMed] [Google Scholar]
  12. Lakhani NA, Narsinghani U, Kumar R. Necrotizing fasciitis of the abdominal wall caused by Serratia marcescens. Infect Dis Rep. 2015;7(2):5774. doi: 10.4081/idr.2015.5774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jarrett P, Rademaker M, Duffill M. The clinical spectrum of necrotising fasciitis. A review of 15 cases. Aust N Z J Med. 1997;27(1):29–34. doi: 10.1111/j.1445-5994.1997.tb00910.x. [DOI] [PubMed] [Google Scholar]
  14. Wong CH, Tan SH. Subacute necrotising fasciitis. Lancet. 2004;364(9442):1376. doi: 10.1016/S0140-6736(04)17197-3. [DOI] [PubMed] [Google Scholar]
  15. Saliba WR, Goldstein LH, Raz R et al. Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2003;22(10):612–614. doi: 10.1007/s10096-003-1023-2. [DOI] [PubMed] [Google Scholar]
  16. Wong CH, Wang YS. What is subacute necrotizing fasciitis?: a proposed clinical diagnostic criteria. J Infect. 2006;52(6):415–419. doi: 10.1016/j.jinf.2005.08.018. [DOI] [PubMed] [Google Scholar]
  17. Ahmad H, Haider J, Siddiqui SS et al. Subacute peristomal necrotizing fasciitis detected during adjuvant chemotherapy for adenocarcinoma rectum: case report on a unique presentation and description of a simple surgical strategy for treatment. Cureus. 2018;10(1):e2075. doi: 10.7759/cureus.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pasternack MS, Swartz MN. Cellulitis, necrotizing fasciitis, and subcutaneous tissue infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia (PA): Churchill Livingstone Elsevier. 2015. pp. 1195–1216.
  19. Tyler K, Patterson A, Hebra A. Necrotizing fasciitis in a healthy pediatric patient caused by Enterobacter cloacae and Serratia marcescens: a discussion of diagnosis and management. Am Surg. 2016;82(9):e292–e293. [PubMed] [Google Scholar]
  20. Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis. 1987;155(1):143–146. doi: 10.1093/infdis/155.1.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bornstein PF, Ditto AM, Noskin GA. Serratia marcescens cellulitis in a patient on hemodialysis. Am J Nephrol. 1992;12(5):374–376. doi: 10.1159/000168475. [DOI] [PubMed] [Google Scholar]
  22. Zipper RP, Bustamante MA, Khatib R. Serratia marcescens: a single pathogen in necrotizing fasciitis. Clin Infect Dis. 1996;23(3):648–649. doi: 10.1093/clinids/23.3.648. [DOI] [PubMed] [Google Scholar]
  23. Huang JW, Fang CT, Hung KY et al. Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy. J Formos Med Assoc. 1999;98:851–854. [PubMed] [Google Scholar]
  24. Liangpunsakul S, Pursell KJ. Community-acquired necrotizing fasciitis caused by Serratia marcescens: case report and review. Eur J Clin Microbiol Infect Dis. 2001;20(7):509–510. doi: 10.1007/pl00011294. [DOI] [PubMed] [Google Scholar]
  25. Newton CL, Delemos D, Abramo TJ et al. Cervical necrotizing fasciitis caused by Serratia marcescens in a 2 year old. Pediatr Emerg Care. 2002;18(6):433–435. doi: 10.1097/00006565-200212000-00007. [DOI] [PubMed] [Google Scholar]
  26. Bachmeyer C, Sanguina M, Turc Y et al. Necrotizing fasciitis due to Serratia marcescens. Clin Exp Dermatol. 2004;29(6):673–674. doi: 10.1111/j.1365-2230.2004.01597.x. [DOI] [PubMed] [Google Scholar]
  27. Curtis CE, Chock S, Henderson T, Holman MJ. A fatal case of necrotizing fasciitis caused by Serratia marcescens. Am Surg. 2005;71:228–230. [PubMed] [Google Scholar]
  28. Statham MM, Vohra A, Mehta DK et al. Serratia marcescens causing cervical necrotizing oropharyngitis. Int J Pediatr Otorhinolaryngol. 2009;73(3):467–473. doi: 10.1016/j.ijporl.2008.10.019. [DOI] [PubMed] [Google Scholar]
  29. Motsitsi NS. Fatal necrotizing fasciitis following human bite of the forearm. J Hand Surg Eur Vol. 2011;36(7):605–605. doi: 10.1177/1753193411411547. [DOI] [PubMed] [Google Scholar]
  30. Vano-Galvan S, Álvarez-Twose I, Moreno-Martín P, Jaén P. Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host. Int J Dermatol. 2012;53:1. doi: 10.1111/j.1365-4632.2011.05440.x. [DOI] [PubMed] [Google Scholar]
  31. Prelog T, Jereb M, Čuček I, Jazbec J. Necrotizing fasciitis caused by Serratia marcescens after venous access port implantation in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34:6. doi: 10.1097/MPH.0b013e318253f047. [DOI] [PubMed] [Google Scholar]
  32. Wen YK. Necrotizing fasciitis caused by Serratia marcescens: a fatal complication of nephrotic syndrome. Ren Fail. 2012;34(5):649–652. doi: 10.3109/0886022X.2012.664508. [DOI] [PubMed] [Google Scholar]
  33. Rehman T, Moore TA, Seoane L. Serratia marcescens necrotizing fasciitis presenting as bilateral breast necrosis. J Clin Microbiol. 2012;50(10):3406–3408. doi: 10.1128/JCM.00843-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Cope TE, Cope W, Beaumont DM. A case of necrotising fasciitis caused by Serratia marsescens: extreme age as functional immunosuppression? Age Ageing. 2013;42(2):266–268. doi: 10.1093/ageing/afs198. [DOI] [PubMed] [Google Scholar]
  35. Majumdar R, Crum-Cianflone NF. Necrotizing fasciitis due to Serratia marcescens: case report and review of the literature. Infection. 2015;44(3):371–377. doi: 10.1007/s15010-015-0855-x. [DOI] [PubMed] [Google Scholar]
  36. Hagiya H, Ojima M, Yoshida T et al. Necrotizing soft tissue infection caused by Serratia marcescens: a case report and literature review. J Infect Chemother. 2016;22(5):335–338. doi: 10.1016/j.jiac.2015.11.013. [DOI] [PubMed] [Google Scholar]
  37. Lin WL, Yeh TC, Lu CH, Huang HK, Chiu WY. A catastrophic cervical necrotizing fasciitis after tooth extraction. Intern Emerg Med. 2015;11(8):1135–1136. doi: 10.1007/s11739-015-1379-1. [DOI] [PubMed] [Google Scholar]
  38. Heigh EG, Maletta-Bailey A, Haight J, Landis GS. Necrotizing fasciitis of the lower extremity caused by Serratia marcescens. J Am Podiatr Med Assoc. 2016;106(2):144–146. doi: 10.7547/15-042. [DOI] [PubMed] [Google Scholar]
  39. Marin L, Rowan R, Mantilla A et al. Lower-extremity infections caused by Serratia marcescens. J Am Podiatr Med Assoc. 2017;107(3):231–239. doi: 10.7547/15-180. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical and Aesthetic Dermatology are provided here courtesy of Matrix Medical Communications

RESOURCES